1-11 of 11
James Blachly
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Revumenib for patients with relapsed or refractory (R/R) Nucleophosmin 1–Mutated (NPM1m) Acute Myeloid Leukemia (AML): Outcomes by prior treatment in the phase 2 AUGMENT-101 study

Free
Martha Arellano, Michael Thirman, John DiPersio, Mael Heiblig, Eytan Stein, Andre Schuh, Andrius Zucenka, Stephane De Botton, Carolyn Grove, Gabriel Mannis, Cristina Papayannidis, Alexander Perl, Ghayas Issa, Ibrahim Aldoss, Ashish Bajel, David Dickens, Michael Kühn, Ioannis Mantzaris, Emmanuel Raffoux, Elie Traer, Irina Amitai, Hartmut Döhner, Corinna Greco, Tibor Kovacsovics, Christine McMahon, Pau Montesinos, Arnaud Pigneux, Paul Shami, Richard Stone, Ofir Wolach, John Harpel, Yakov Chudnovsky, Li Yu, Rebecca Bagley, Angela R. Smith, James Blachly
Journal: Blood
Blood (2025) 146 (Supplement 1): 3418.
https://doi.org/10.1182/blood-2025-3418
Published: 2025
Journal Articles

Evaluation of cytarabine consolidation dosing in older adult patients with Acute Myeloid Leukemia

Free
Pooja Kumar, Deedra Nicolet, Tracelyn Freeman, Lexus Frazier, Allyson Waller, Megan Fleming, Michael Walker, Gregory Behbehani, James Blachly, Uma Borate, Nicole Grieselhuber, Shivani Handa, Jayanshu Jain, Karilyn Larkin, Meixiao Long, Ann-Kathrin Eisfeld, Alice Mims
Journal: Blood
Blood (2025) 146 (Supplement 1): 3408.
https://doi.org/10.1182/blood-2025-3408
Published: 2025
Journal Articles

Assessment of EBV DNA methlyation to guide antiviral use in EBV-associated lymphoma

Free
Cara Noel, Christoph Weigel, Haley Klimaszewski, Kurtis Host, Yue-Zhong Wu, Sarah Schlotter, Elshafa Ahmed, Eric Brooks, James Blachly, Mark Lustberg, Timothy Voorhees, Christopher Oakes, Robert Baiocchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 1752.
https://doi.org/10.1182/blood-2025-1752
Published: 2025
Journal Articles

Real world experience of patient outcomes in a dedicated clonal hematopoiesis hematology clinic

Free
Jayanshu Jain, Julia Cooper, Halle Wade, Marina Beltrami Moreira, James Blachly, Nicole Grieselhuber, Bethany Mundy-Bosse, Uma Borate
Journal: Blood
Blood (2025) 146 (Supplement 1): 3167.
https://doi.org/10.1182/blood-2025-3167
Published: 2025
Journal Articles

Ziftomenib in combination with venetoclax and azacitidine in newly diagnosed NPM1-m acute myeloid leukemia: Phase 1b results from KOMET-007

Free
Gail Roboz, Eunice Wang, Amir Fathi, Harry Erba, Keith Pratz, Guru Subramanian Guru Murthy, Leonard Alsfeld, James Blachly, Kiran Naqvi, Ghayas Issa, Ayman Qasrawi, Stephen Strickland, Neil Palmisiano, Jessica Altman, Cecilia Arana Yi, Grerk Sutamtewagul, Yazan Madanat, Suresh Kumar Balasubramanian, Christine McMahon, Hongling Zhang, Tianle Chen, Marcie Riches, Daniel Corum, Mollie Leoni, Amer Zeidan
Journal: Blood
Blood (2025) 146 (Supplement 1): 766.
https://doi.org/10.1182/blood-2025-766
Published: 2025
Journal Articles

Toxicity of reduced dose versus standard dose pegaspargase in adolescents and young adults with acute lymphoblastic leukemia

Free
Megan Fleming, Allyson Waller, Subodh Bhatta, Pooja Kumar, Tracelyn Freeman, Lexus Frazier, Nilmarie Ayala-Fontanez, Adithya Ghantae, Sharon Loo, Jasmine Kainth, Ying Huang, James Blachly, Bradley Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole Grieselhuber, Shivani Handa, Jayanshu Jain, Karilyn Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Gregory Behbehani
Journal: Blood
Blood (2025) 146 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2025-3344
Published: 2025
Journal Articles

The bromodomain and extra-terminal domain protein BRD4 promotes both self renewal and inflammation in TET2 mutated clonal hematopoiesis

Free
Alexander Marr, Madeline Halpin, Dominique Corbin, Britten Gordon, Somi Benrashid, Ethan Whipp, Mehdi Gharghabi, Jean Truxall, Olivia Cahn, Rathan Kumar, Parvarthi Ranganathan, Bethany Mundy-Bosse, Jennifer Woyach, Julia Cooper, Marina Beltrami Moreira, Jayanshu Jain, James Blachly, Uma Borate, Rosa Lapalombella, Nicole Grieselhuber
Journal: Blood
Blood (2025) 146 (Supplement 1): 1398.
https://doi.org/10.1182/blood-2025-1398
Published: 2025
Journal Articles

Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study

Free
Alice Mims, Lai Wei, Eric McLaughlin, Jayanshu Jain, Joshua Zeidner, Olatoyosi Odenike, Sangeetha Venugopal, James Blachly, Vu Duong, Anand Patel, Eric Eisenmann, Shelley Orwick, Daelynn Buelow, Gregory Behbehani, Richard Little, Steven Gore, Sharyn Baker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5206.
https://doi.org/10.1182/blood-2025-5206
Published: 2025
Journal Articles

The MEASURE Genome Atlas: Acute Myeloid Leukemia at diagnosis and complete remission

Free
Kai Yu, Laura Dillon, Jesse Tettero, Gege Gui, Rasha Al-Ali, Michael Grunwald, Elizabeth Krakow, Elizabeth Griffiths, Alexandra Gomez-Arteaga, Rahul Vedula, Melhem Solh, Amandeep Salhotra, Nelli Bejanyan, Lori Muffly, Antonio Jimenez-Jimenez, Michael Drazer, Yi-Bin Chen, Aaron Logan, Reena Jayani-Kosarzycki, Sophia Balderman, James Blachly, Brian Shaffer, Marc Schwartz, Cecilia Yeung, Lawrence Druhan, Vanessa Kennedy, Sandeep Gurbuxani, Melissa Tjota, Max Smith, Farah Sahoo, Dylan Barfield, Jim Guo, James Han, Jason Hu, Heejoon Jo, Vidya Kudlingar, Wilfred Li, Yutong Qiu, Pratheesh Sathyan, Sean Truong, Severine Catreux, Sam Ng, Khai Luong, Yunjiao Zhu, Reem Bahr, Jamie Diemer, Jianqun Kou, Stephanie Bo-Subait, Jackie Bjerke, Steven Devine, Bergetta Dietel, Christina Ferrone, Gabrielle Giammarino, Emily Heying, Emily Kolb, Danielle O'Donnell Vitali, Wael Saber, Stephen Spellman, Brenna Tesch, Jenny Vogel, Stephanie Waldvogel, Syreeta Weatherspoon, Jeffery Auletta, Christopher Hourigan
Journal: Blood
Blood (2025) 146 (Supplement 1): 455.
https://doi.org/10.1182/blood-2025-455
Published: 2025
Journal Articles

Revumenib for patients with relapsed or refractory (R/R) KMT2Ar acute leukemia: Outcomes by leukemia type in the phase 2 AUGMENT-101 study

Free
Ibrahim Aldoss, Ghayas Issa, James Blachly, Michael Thirman, Gabriel Mannis, Martha Arellano, John DiPersio, Elie Traer, C. Zwaan, Neerav Shukla, Branko Cuglievan, Carolyn Grove, Matthew Greenwood, Christine McMahon, Alexander Perl, Richard Stone, Cristina Papayannidis, David Dickens, Mael Heiblig, Andrius Zucenka, Pau Montesinos, Ioannis Mantzaris, Tibor Kovacsovics, Paul Shami, Li Yu, Rebecca Bagley, Angela R. Smith, Eytan Stein
Journal: Blood
Blood (2025) 146 (Supplement 1): 1001.
https://doi.org/10.1182/blood-2025-1001
Published: 2025
Journal Articles

Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL

Free
CME Clinical Trials & Observations
Jennifer A. Woyach, Gabriela Perez Burbano, Amy S. Ruppert, Cecelia Miller, Nyla A. Heerema, Weiqiang Zhao, Anna Wall, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry A. Rogers, Sameer A. Parikh, Deborah M. Stephens, Jennifer R. Brown, Gerard Lozanski, James Blachly, Sreenivasa Nattam, Richard A. Larson, Harry Erba, Mark Litzow, Selina Luger, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Richard F. Little, Shira Dinner, Richard M. Stone, Geoffrey Uy, Wendy Stock, Sumithra J. Mandrekar, John C. Byrd
Journal: Blood
Blood (2024) 143 (16): 1616–1627.
https://doi.org/10.1182/blood.2023021959
Published: 2024
Includes: Supplemental data